Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Treatment of HIV/AIDS

Article Abstract:

Physicians treating human immunodeficiency virus (HIV) positive patients are always faced with complex challenges while treating patients but thanks to research papers being published in various medical journals they have an idea of advances made in the cure to the disease. Government agencies must also ensure that research findings are well published or more funding is provided for areas that are neglected and all institutions must ensure translation of research papers published in other languages.

Author: Sande, Merle A., Ronald, Allan
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
Periodical Publishers, Periodicals, Offices & clinics of medical doctors, Physicians & Surgeons, Offices of Physicians (except Mental Health Specialists), Medical Periodicals, Usage, Evaluation, Physicians, Medical journals

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Highly active antiretroviral therapy and sexual risk behavior

Article Abstract:

Highly active antiretroviral therapy (HAART) was made available to human immunodeficiency virus (HIV) patients in the US along with the rest of the developed world in 1996 and it has shown reduced HIV-RNA levels in many of these patients. Studies have shown that HIV-positive patients receiving HAART do not display increased sexual behavior even after therapy has shown decrease in viral load.

Author: Marks, Gary, Crepaz, Nicole, Hart, Trevor A.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
Dosage and administration, Highly active antiretroviral therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort

Article Abstract:

An examination of early disease progression and survival in a population-based cohort with perinatal HIV infection in relation to year of birth and use of antiretroviral therapy (ART) is presented. The results led to the conclusion that the population-based cohort demonstrated decreased early HIV progression and improved survival at age 3 years, associated with more advanced theory.

Author: Berk, David R., Hill, David W., Falkovitz-Halpern, Meira S., Albin, Catherine, Bork, Jane M., Arrieta, Antonio, Cohan, Deborah, Petru, Ann, Nilson, Bjorn, Ruiz, Juan, Wenman, Wanda, Weintrub, Peggy Sue, Maldonado, Yvonne A.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Health aspects, Risk factors, Antiviral agents, Antiretroviral agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, United States, HIV infection, HIV infections
Similar abstracts:
  • Abstracts: Two-year clinical evaluation of a packable resin-based composite. Orthodontic treatment with a series of removable appliances
  • Abstracts: Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii
  • Abstracts: Naturally occurring immunomodulation: SIV infection in sooty mangabeys. Simian immunodeficiency virus infection of hematopoietic stem cells and bone marrow stromal cells
  • Abstracts: Dickkopf-1 is a master regulator of joint remodeling. Clinical implications of the Osteoprotegerin/RANKL/RANK system for bone and vascular diseases
  • Abstracts: Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.